A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
Elizaveta Gribaleva(King's College London), Carsten Flohr(King's College London), Niels Steen Krogh(Synlab Czech (Czechia)), Thomas Werfel(Medizinische Hochschule Hannover), Dmitri Wall(Children's Health Ireland at Crumlin), Simon Francis Thomsen(University of Copenhagen), Ahmet Akkoç(Synlab Czech (Czechia)), Wouter Ouwerkerk(University of Amsterdam), Dan Henrohn(Uppsala University), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), Abaigeal Jackson(Vhi Healthcare), Ida Vittrup(Leo Pharma (Denmark)), Rayka Malek(King's College London), Lara Cutlar(University College Dublin), G. Fletcher(Cystic Fibrosis Ireland), Bolaji Coker(King's College London), Jochen Schmitt(University Hospital Carl Gustav Carus), Phyllis I. Spuls, Alan D. Irvine(Trinity College Dublin), Thomas Birkner(University Hospital Carl Gustav Carus), Con Hennessy(University College Dublin), Stephan Weidinger(University Hospital Schleswig-Holstein), Ariënna Hyseni(Amsterdam UMC Location University of Amsterdam), Rowena Randall(Pfizer (United Kingdom)), David Prieto-Merino(King's College London), K.T. Chan(St Thomas' Hospital), Erwin Bruninx(Pfizer (United States)), Anne Grete Frøstrup(Pfizer (United Kingdom))
Cited by 1
Related Papers
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
|Allergy|2014|1.4k
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology
|Allergy|2014|1k
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
|Nature Genetics|2012|1k
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892